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Actinobacillus pleuropneumoniae is a mucosal respiratory pathogen causing
contagious porcine pleuropneumonia. Pathogenesis studies have demon-
strated a major role for the capsule, exotoxins and outer membrane proteins.
Actinobacillus pleuropneumoniae canalsoglycosylateproteins, usingacytoplasmic
N-linked glycosylating enzyme designatedNGT, but its transcriptional arrange-
ment and role in virulence remains unknown. We investigated the NGT locus
and demonstrated that the putative transcriptional unit consists of rimO,
ngt and a glycosyltransferase termed agt. From this information we used the
A. pleuropneumoniae glycosylation locus to decorate an acceptor protein, within
Escherichiacoli,withahexosepolymer that reactedwithananti-dextranantibody.
Mass spectrometryanalysisof a truncatedproteinrevealed that thisoperoncould
addup to 29 repeatunits to the appropriate sequon.Wedemonstrated the impor-
tance of NGT in virulence, by creating deletion mutants and testing them in a
novel respiratory cell line adhesion model. This study demonstrates the impor-
tance of the NGT glycosylation system for pathogenesis and its potential
biotechnological application for glycoengineering.
1. Introduction
Actinobacillus pleuropneumoniae is a Gram-negative bacterium and the causative
agent of porcine pleuropneumonia, a severe respiratory disease responsible for
significant losses to the pig industry worldwide. Economically, this disease has
a huge impact on the pig industry, costing an average E6.4 per fattened pig in
an affected herd in Europe [1]. Actinobacillus pleuropneumoniae enters the lungs
and colonizes tissues by binding to mucus proteins and cells of the lower respirat-
ory tract, including ciliated cells of the terminal bronchioli and alveolar epithelial
cells [2,3]. There are 15 established serovars that differ in capsular polysaccharide
composition [4], with another proposed based on serological results [5]. Several
surface structures have been identified as being involved in adhesion, including
fimbriae [6] and lipopolysaccharide (LPS) [7].
Advances inDNAsequencing technologies andmass spectrometry techniques
reveal that post-translational modification of proteins by glycosylation is not
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Figure 1. Genetic organization of the HMWC enzyme family. In contrast to other bacteria, NTHi has two copies of the HMW locus, and each has a gene encoding
an acceptor protein. A. pleuropneumoniae is the only species that has a second glycosyltransferase adjacent to the N-linking enzyme.
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2restricted to a few bacterial species and is often important in
pathogenesis [8,9]. Understanding the mechanisms of bacterial
glycosylation and its role in pathogenesis can have practical
applications such as the design of novel bioglycoconjugate vac-
cines, antimicrobials and diagnostics [10,11]. Bacterial protein
glycosylation systems can bebroadly divided into twomain cat-
egories: glycans that are covalently attached to amide groups of
asparagine residues (N-linked) or tohydroxyl groupson serine/
threonine residues (O-linked). These categories can be further
subdivided depending on the cellular compartment where
protein glycosylation takes place. Oligosaccharyltransferases
(OTases) function in the periplasmic compartment of a bacterial
cell and catalyse the transfer of an oligosaccharide from a lipid
donor to an acceptor molecule, usually a protein. The best-
studied bacterial OTases are the C. jejuni PglB system, where
en bloc glycosylation operates through an N-OTase [12,13],
and the Neisseria meningitidis O-OTase PglL. N- and O-linked
glycosylation can also occur in the cytoplasmic compartment
of the bacterial cell, mediated through the action of glyco-
syltransferases that use nucleotide activated sugar donors as
substrates for transfer onto the acceptor protein. Examples of
cytoplasmic glycosylation can be found in Clostridium difficile,
where flagellin is O-glycosylated [14], and non-type-able
Haemophilus influenzae (from here on referred to as NTHi) [15],
where two copies of a cytoplasmic N-linked glycosylation
modify a high-molecular-weight adhesin with hexoses using
the enzyme HMWC. In NTHi, all proteins responsible
for high-molecular-weight adhesin synthesis, transport and
glycosylation are encoded in the same locus.
Actinobacillus pleuropneumoniae also carries a cytoplasmic
N-linking glycosyltransferase, known as NGT. It is a member
of the HMWC-like glycosyltransferase family [16–20], but
lacks an adjacent adhesin or transporter and its transcriptio-
nal unit remains to be characterized. Recently, studies into the
human pathogensKingella kingae andAggregatibacter aphrophilus
[21] demonstrated a similar genetic arrangement. These ‘orphan’
HMWC enzymes have been found to glycosylate trimericautotransporter adhesins, encoded in distant locations of the
genome [21].Autotransporterproteins, suchas the trimeric auto-
transporter adhesin (TAA) Apa found in A. pleuropneumoniae,
mediate attachment to host cells [22]. Apa is predicted to have
an N-terminal signal peptide for secretion, a functional
passenger domain containing head, neck and stalk motifs, and
a conserved C-terminal translocator domain [22]. However,
A. pleuropneumoniae has a unique chromosomal feature.
Adjacent to ngt, there is a second ORF, which we named agt,
coding for an accessory glycosyltransferase (figure 1).
When agt is heterologously expressed in Escherichia coli and
purified, it can be used in vitro, to add further glucose residues
to the N-linked glycan that NGT generates [19]. However, agt
has never been demonstrated to function in vivo in conjunction
with ngt. In addition, no virulence phenotype has been
reported in A. pleuropneumoniae for this glycosylation locus
owing to known difficulties in constructing genetic mutations
in this organism.
In this study,we report thegeneration ofA. pleuropneumoniae
ngt and agt deletion mutants, and demonstrate a biological role
for thisN-linked glycosylation system using a human adenocar-
cinoma lung epithelial cell adhesion assay. Our results suggest
that ngt is part of an operon that contains the upstream ORF
rimO, encoding a methylthiotransferase, and the downstream
ORF agt, encoding ana-6-glucosyltransferase (a6GlcT). Further-
more, we were able to clone and express ngt and agt in E. coli,
demonstrating for the first time, to the best of our knowledge,
the in vivo assembly of N-linked dextran.2. Material and methods
2.1. Bacterial strains used and culture conditions
Actinobacillus pleuropneumoniae serovar 15 reference strain,
HS143, or derived mutants were grown at 378C with 5% CO2
on BHI (Oxoid, UK) agar or broth, supplemented with
rsob.royalsocietypublishing.org
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310 mg ml
21 nicotinamide adenine dinucleotide (NAD) and
when required with kanamycin (50 mg ml21) or chlorampheni-
col (1 mg ml21). Escherichia coli TOP10 and Mu Free Donor
(MFD) [23] were grown in LB broth or agar (Oxoid) sup-
plemented, when required, with 50 mg ml21 kanamycin at
378C. E. coli DH10 were grown in LB broth or agar (Oxoid)
at 378C supplemented, when required, with 80 mg ml21
spectinomycin and/or 100 mg ml21 trimethoprim.
2.2. Genomic DNA extraction
Total genomic DNA was extracted from a 10 ml overnight
culture of A. pleuropneumoniae HS143, using a proteinase K
and phenol: chloroform: isoamyl-alcohol-based procedure as
previously described by Cuccui et al. [24].
2.3. Construction of Actinobacillus pleuropneumoniae
knockout mutants
The A. pleuropneumoniae HS143 orthologues of apl_1634 and
apl_1635 (also known as agt and ngt, coding for a6GlcT
and NGT, respectively), found in the A. pleuropneumoniae L20
genome [25], were deleted using our recently described
unmarked mutation system [26]. Primers used to generate the
cat-sacB insertion/deletion and theunmarkeddeletion constructs
for each gene are shown in electronic supplementary material,
table S2. Briefly, the target genes and approximately 600–
900 bp of flanking sequences were amplified using CloneAmp
HiFi PCR Premix (Clontech), A-tailed and cloned into pGEMT
(Promega), as previously described [26]. Inverse PCR was then
usedtoopenuptheclones,using theappropriateprimers, remov-
ing the target sequence and adding 15 bp overhangs to allow
insertion of the cat-sacB cassette by In-Fusion cloning (Clontech).
Unmarked deletion constructs were generated by amplifying the
left and right flanking sequences for eachgene, using appropriate
primers with added 15 bp overhangs designed to allow direct
fusion by overlap-extension PCR. The unmarked deletion
mutants were then obtained by two sequential rounds of natural
transformation as previously described [27].
2.4. Plasmid complementation
The vector pMKExpress [28] was digested with EcoRI and SacI
(New England Biolabs, UK) and the resulting digest was
gel purified using a Qiagen MinElute gel extraction kit
(Qiagen, UK) according to the manufacturer’s instructions, to
remove the GFP coding ORF.
The ngt genewas PCR amplified usingAccuprime TaqHifi
(Invitrogen, UK) using the forward primer ngtCOMPFWD
(50-TTTTGAATTCGTGGGTAAAACGCTTGCAGT-30) and
reverse primer ngtCOMPREV (50-TTTTGAGCTCTTAATTTT
CTTTTAGGAACGCATTT-30). The agt gene was amplified
using the primers agtCOMPFWD (50-AAACTGCAGATTA
AATGCGTTCCTAAAAGAAAA-30) and agtCOMPREV (50-
TTT GCGGCCGCTTAACTCCGACTATTCTCAAG-30).
When agt only complementation failed, complementation
with ngt–agt was attempted. Both ORFs were PCR amplified
using Accuprime Taq Hifi (Invitrogen) using the forward
primer ngtagtCOMPFWD (50-TTTGAATTCCGAGCAAGAA
GTGAAAGTCG-30) and reverse primer ngtagtCOMPREV
(50-TTTGCGGCCGCCACCGATAGCCGTATTTCGT-30) with
the following cycling conditions: 948C/30 s followed by24 cycles of 948C/30 s, 538C/30 s, 688C/2 min and a final
688C/5 min cycle. All ORFS were expressed under the control
of the plasmid promoter.
The resulting ngt only PCR product was digested with
EcoRI and SacI, the agt only product was digested with PstI
and NotI, and the ngt–agt PCR product was digested with
EcoRI andNotI before being purified using a Qiagen PCR puri-
fication kit. Digested vector and PCR products were ligated
using Promega T4 DNA ligase (Promega, UK) to yield the
vectors pMKngt, pMKagt and pMKngt–agt, prior to transform-
ation of the plasmid into One Shot E. coli TOP10 cells
(Invitrogen) according to manufacturer’s instructions. Trans-
formants were selected on LB agar supplemented with
kanamycin (50 mg ml21). The complementation vectors were
transformed into the mutant recipient strains by natural
transformation as previously described [27].
2.5. Cell culture
The A549 cell line, adenocarcinoma human alveolar basal epi-
thelial cells, (ATCC, CCL-185, US) was grown at 378C, 5% CO2
in F-12 K medium (Gibco) supplemented with 10% fetal calf
serum (Sigma).
2.6. Adhesion assay using A549 cell line
The A549 cell line (ATCC, CCL-185, USA) was seeded into
12-well tissue culture plates at a concentration of 2.5
105 cells ml21 and incubatedovernight at 378C5%CO2.Bacterial
overnight cultures (HS143 wild-type, isogenic ngt and agt
mutants and complemented mutants) were used to seed into
BHI–NAD medium and grown to an OD600nm of 0.6. One
millilitre of the suspensionwas added to theA549 cells at amul-
tiplicity of infection (MOI) of 100 : 1, and the plates incubated at
378C5%CO2. After 3 h, non-adherent bacteriawere removed by
washing three timeswith 1 ml DPBS (Gibco), and adherent bac-
teria were released by adding 100 ml of 0.25% trypsin–EDTA
(Sigma) for 5 min at 378C. Trypsinization was stopped by the
addition of 900 ml of DPBS. Serial dilutions were plated onto
BHI–NAD plates for quantification of adherent bacteria. In
order to determine if any of the recovered bacteria had invaded
theA549 cells, controlswere treatedwith gentamycin (Sigma) at
a final concentration of 10 mg ml21 for 1 h to allow for killing of
adherent extracellular bacteria. The cells were then lysed by the
addition of ice-cold sterilewater, and serial dilutionswereplated
out on BHI–NAD.
2.7. Statistical analysis of adhesion assay data
The number of adherent cells was calculated by counting the
colony forming units and comparing with the initial inoculum
of each individual culture to determine the percentage of
adherent cells. The statistical analysis was performed using a
one-way analysis of variance followed by a Bonferroni’s mul-
tiple comparison test. The significance level was set at 0.05
throughout. Statistical analysis was done using GraphPad
PRISM v. 4.00 for Windows (GraphPad Software, San Diego,
CA, www.graphpad.com).
2.8. Reverse transcriptase PCR
An overnight culture ofA. pleuropneumoniaeHS143was diluted
1 : 20 in BHI–NAD broth. At the time points of 1.5, 3.0, 5 and
rsob.royalsocietypublishing.org
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424 h, RNAwas extracted as previously described [29], with the
minor modification that 2 mg of total RNA from each sample
was treated with Ambion TURBO DNase (Invitrogen) accord-
ing to the manufacturer’s instructions. cDNA was generated
from DNase-treated RNA using the SuperScript II kit (Invitro-
gen) according to the manufacturer’s instructions. For each
sample, 2 ml of reverse transcribed cDNA was used as a tem-
plate in a 25 ml total volume PCR mixture and amplified
using MyTaq master mix (Bioline, UK) using the following
cycling conditions: 948C/30 s, followed by 35 cycles of 948C/
10 s, 538C/10 s, 728C/10 s and a final single 728C/30 s cycle
using the primers listed in electronic supplementary material,
table S2.Biol.7:1602122.9. Quantitative real-time PCR validation
Total RNA was extracted from bacteria grown in BHI–NAD
broth by using Tri Reagent (Sigma, UK) as previously
described. Two micrograms from each sample was treated
with Ambion TURBO DNase (Invitrogen) according to man-
ufacturer’s instructions with some modifications. Total RNA
was incubated for 1 h at 378C followed by the addition of
another two units of DNase. The sample was then incubated
for an extra 1 h before inactivation.
cDNA was generated from DNase-treated RNA using
the SuperScript III kit (Invitrogen) using random hexamers
(Invitrogen) according to the manufacturer’s instructions. One
microlitre of this material was used in a QPCR using SYBR
Green dye-based PCR amplification and detection system
(Applied Biosystems). The A. pleuropneumoniae HS143 WT,
HS143Dngt and HS143Dagt were analysed for absolute quanti-
fication of cDNA using an ABI7500 Fast instrument (Applied
Biosystems). Amplification was carried out using the following
primers at a final concentration of 500 nM. agtfwd: 50-GATTGG
ATA GGT GAA GGC GA-30, agtrev: 50-CCC TTG CTC AAA
ATG ACG GA-30, ngtfwd: 50-AGT TTG TGA GAG CAACGG
TG-30, ngtrev: 50-AGT CCG AAT GTG TTG TTG CC-30,
rimOfwdv2: 50-CGT CCG ATT GTG CAA GTG TT-30, rimOr-
evv2: 50-CAC CGT TCC AGA AAA CCG TT-30. Samples
tested were four biological replicates, each tested as three
technical replicates.
For comparative qRTPCR analysis of A. pleuropneumoniae
HS143 WT, HS143Dngt and HS143Dagt, gene induction or
reduction valueswere calculated by comparing the normalized
values of the wild-type and mutant samples, using the statisti-
cal formulation for the threshold cycle (DDCT) method. The
threshold value of each gene was first normalized to the
value of the constitutively expressed control gene glyA [30]
(glyA primers: fwd: 50-CAA GCG AAT GCA GCT GTT
TA-30, glyArev: 50- CTG TGA TGC CGT AGA GGA CA-30).2.10. Subcloning and heterologous expression of agt
and ngt
The putative NGT operon was PCR amplified using
the primers ngt-agtfwd: 50-TTTTGAATTCCGAGCAAGAAG
TGAAAGTCG-30 and ngt-agtrev: 50-TTTTTGGTACCCACC
GATAGCCGTATTTCGT-30 using Accuprime Taq Hifi (Invi-
trogen) and the following cycling conditions: 948C/30 s,
followed by 24 cycles of 948C/30 s, 538C/30 s, 688C/4 min
and a final cycle of 688C/5 min.The amplicon was ligated into the vector pEXT20 using T4
DNA ligase (New England Biolabs, UK) following digestion
of the plasmid and the PCR product with EcoRI and KpnI.
Escherichia coliNEB10b (New England Biolabs, UK) was trans-
formed with the ligation reaction generating the plasmid
pJC78. Expression was induced by growing an E. coli colony
in LB broth with ampicillin 100 mg ml21 until an OD600 of 0.4
was reached. At that point 1 mM, IPTG was added, and the
cultures were incubated at 378C with shaking for a further
16 h. Expression of NGT and a6GlcT was monitored using
SDS–PAGE, Coomassie staining and western blotting.
2.11. Glycosylation of AtaC by NGT and a6GlcT in
Escherichia coli cells
Escherichia coli DH10b cells carrying pJC78 were transformed
with the construct pMLBADAtaC1866–2428 [17], and cultured
in LB broth with ampicillin 100 mg ml21, trimethoprim
20 mg ml21 at 378C with shaking until an OD600nm of 0.4 was
reached, followed by induction with 0.2% L-arabinose and
1 mM IPTG. After 16 h incubation, AtaCwas purified. The bac-
terial cell pellet was isolated by centrifugation at 6000g for
10 min and lysed using a cell homogenizer (Stansted Fluidics
Ltd. SPCH-10). Any intact cell debris was thereafter pelleted
by centrifugation at 10 000g for 30 min before purification
from the supernatant using an Ni–NTA (Qiagen, UK) gravity
column (Thermo Scientific, USA).
Glycosylated product was analysed by SDS–PAGE and
transferred onto a nitrocellulose membrane before being
analysed by immunoblot using a mouse anti-His antibody
(AbCam,UK) and an IRDye 680CWgoat anti-mouse conjugate
secondary antibody. Detection of fluorescent signal was
carried out using a LI-COR imaging system.
2.12. Mutagenesis of the ngt locus
The cloned locus coding for NGT and a6GlcT was mutated
using the QuickChange XL II site-directed mutagenesis kit
(Agilent Technologies, CA) using the following primers.
agtt120a_antis: 50-CAAAACAGAAGTAAACGTTTTAATC
TATATTATTTTCCATAACAT AACCTTAAGAGCC-30 and
agtt120a: 50-GGCTCTTAAGGTTATGTTATGGAAAATAAT
ATAGATTAAAACGTTTACTTCTGTTTTG-30 (underlined
nucleotide denotes the change).
The ngt gene was mutated using the following primers:
ngta1321g_a132: 50-CGGTATAGCTTCAACCACGATGGCG
CTAAATCCGTATTT CTTAGAA-30 and ngta1321g_a132: 50-
TTCTAAGAAATACGGATTTAGCGCCATCGTGGTTGAAG
CTATACCG-30 (underlined nucleotides denotes the change).
The following conditions were used: 958C/60 s followed by
18 cycles of 958C/50 s, 608C/50 s, 688C/8 min and a final
688C/7 min cycle.
Following amplification, the PCR products wereDpnI trea-
ted according to the manufacturer’s instructions and used to
transform E. coli XL-10 Gold cells (New England Biolabs, UK).
2.13. Western blot analysis of glycosylated AtaC
Purified AtaC from E. coli DH10b was analysed by western
blotting. Unglycosylated, fully glycosylated andmonoglycosy-
latedAtaCwere analysed by dot blot by placing a 3 ml drop of a
1 mg ml21 solution of protein or dextran (dextran standard
rsob.royalsocietypublishing.org
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5MW 1000 from Leuconostoc, Sigma-Aldrich UK) onto a nitro-
cellulose blotting membrane (Amersham Protran, GE
HealthCare, Germany) and allowing to air dry before blocking
the membrane by incubating with phosphate-buffered saline,
2% milk solution for 1 h at room temperature. The membrane
was then probed using a 1 : 1000 dilution of a mouse mono-
clonal antibody raised specifically against a tetrasaccharide of
a1–6 linked glucose (MS a-Dextran Clone Dx1, Stem Cell
Technologies, Canada). An IRDye 680CW goat anti-mouse
antibody at a 1 : 10 000 dilutionwas used as the secondary anti-
body. Thewestern blot imageswere visualized using a LI-COR
imaging system.
2.14. Analysis of N-glycans released from AtaC
Glycans were released from 200 mg AtaC using the Ludger
Liberate Hydrazinolysis kit, according to the manufacturer’s
recommendations. The released glycans were fluorescently
labelled with 2-aminobenzamide (2-AB) as described pre-
viously [31]. Excess labelling reagent was removed as
follows: four discs of filter paper (Whatman) were soaked
in 30% acetic acid, inserted into a 1 ml plastic syringe and
washed sequentially with 2  1 ml acetic acid, 2  1 ml
water, 2  1 ml acetonitrile (ACN) and finally 2  1 ml 95%
ACN. The labelled glycans were diluted to 500 ml with 95%
ACN and loaded onto the column. Of 500 ml 95% ACN was
used to rinse the labelling tube and was added onto the
column as well. The column was washed with 8  1 ml
95% ACN and glycans were finally eluted in 50 ml water
twice. Elution fractions were pooled and passed through a
0.45 mm filter (Ultrafree-MC Durapore HV filter unit, Milli-
pore) before analysis by normal-phase HPLC (Supelcosil
LC-NH2 column, 80–20% ACN gradient over 90 min, fluor-
escence detection at 320 nm excitation and 420 nm emission
wavelength). Glyko 2-AB glucose homopolymer standard
(Prozyme) was used as a reference. The identity of the
labelled glycans was confirmed by MALDI mass spec-
trometry. Samples were mixed 1 : 1 with dihydroxybenzonic
acid matrix (15 mg ml21 in 75% ACN in water with 0.1%
formic acid (FA)), and spotted onto a matrix-assisted laser
desorption/ionization time of flight mass spectrometry
(MALDI-TOF–TOF MS) target plate. Data acquisition was
performed manually on a Model 4800 Proteomics Analyser
(Applied Biosystems, Framingham, MA) with an Nd : YAG
laser, and 1000 shots were accumulated in the reflectron
positive ion mode.
2.15. Nano-LC–ESI–MS/MS analysis of
glycosylated AtaC
For structural analysis, 50 mg of AtaC was reduced, alkylated
and digested with trypsin using the filter-aided sample prep-
aration protocol [32]. Samples were analysed on a calibrated
LTQ-Orbitrap Velos mass spectrometer (Thermo Fischer
Scientific, Bremen, Germany) coupled to an Eksigent-Nano-
HPLC system (Eksigent Technologies, Dublin (CA)). Peptides
were resuspended in 2.5% ACN and 0.1% FA, and loaded on a
self-made tip column (75 mm  80 mm) packed with reverse
phase C18 material (AQ, 3 mm 200 A˚, Bischoff GmbH,
Leonberg, Germany) and eluted with a flow rate of 200 nl
per min by a gradient from 3% to 30% ACN, 0.1% FA in
22 min, 50% ACN, 0.1% FA in 25 min, 97% ACN, 0.1% FA in27 min. One scan cycle comprised a full-scan MS survey spec-
trum, followed by up to 20 sequential collision-induced
dissociation (CID) MS/MS on the most intense signals above
a threshold of 1500. Full-scan MS spectra (400–2000 m/z)
were acquired in the FT-Orbitrap at a resolution of 60 000 at
400 m/z, whereas CID MS/MS spectra were recorded in the
linear ion trap. CID was performed with a target value of 1e4
in the linear trap, collision energy at 35 V, Q-value at 0.25
and activation time at 30 min. AGC target values were 5e5
for full FTMS scans and 1e4 for ion trap MSn scans. For all
experiments, dynamic exclusion was used with one repeat
count, 15 s repeat duration and 60 s exclusion duration.
2.16. Database analysis and identification of modified
residues
MS and MS/MS data were processed into Mascot generic
format files and searched against the Swissprot database
(version 201402) through the Mascot engine (v. 2.2) with
the consideration of carbamidomethylation at cysteine, oxi-
dation at methionine and N-hexosylation at Asparagine. The
monoisotopic masses of 2 þ or more charged peptides were
searched with a peptide tolerance of 10 ppm and an MS/MS
tolerance of 0.6 Da for fragment ions. Only peptides with a
maximum of two missed cleavage sites were allowed in data-
base searches. Positive identification of hexosylated peptides
was performed by manual inspection of spectra. Peptides
modified with extended glycan chains were investigated
manually, and their corresponding MS/MS spectra were
annotated. Here, XCALIBUR v. 2.2 sp1.48 was used for data pro-
cessing, and MS deconvolution was performed by XtractRaw
file from Thermo Scientific.
2.17. Construction of acceptor protein JC1
Amino acid residues 23–163 of Cj0114 from C. jejuni NCTC
11168 were used as a scaffold to design a novel acceptor
protein. The native signal sequence from residues 1 to 23 was
removed along with the native tetratricopeptide domain
encoded within residues 164–315. Twelve NAT glycosylation
sequons were added at the C-terminus of the new protein,
each separated by a proline and a glycine. Finally, a hexa-
histidine tag was added to the C-terminus to enable protein
purification. This construct was DNA synthesized (Celtek
Genes, USA) and subcloned into BamHI and SphI digested
expression vector pACYC184.3. Results
3.1. NGT and a6GlcT are required for adhesion
of Actinobacillus pleuropneumoniae HS143 to
A549 cell lines
Within the genome of A. pleuropneumoniae strain HS143, we
identified two ORFs, orthologues of apl_0104 (70% identity,
BlastP) and apl_0443 (82% identity, BlastP) in the L20 genome
[25], coding for autotransporter adhesins. In silico analysis
revealed that these adhesins have 75 and 95 N-X-(S/T)
sequons, respectively (PROGLYCPROT). Naegeli et al. [17] car-
ried out mass spectrometry analysis of A. pleuropneumoniae’s
proteome for strain 4074 serotype 7, and the only
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Figure 2. Percentage of adhesion of A. pleuropneumoniae strain HS143, iso-
genic mutants and complemented mutants to A549 cells infected at an MOI
of 100 : 1 for 3 h prior to quantification of adherence. Horizontal bars indicate
pairs of columns that are significantly different when compared with the
wild-type HS143 (p, 0.05).
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6glycopepetides identified belonged to two autotransporter
adhesins [17], making these two adhesins the only native
substrates for NGT identified so far. In NTHi, deletion of the
N-linked glycosylation system results in a significantly reduced
adherence phenotype [15]. In order to investigate whether this
was the case for A. pleuropneumoniae, adhesion of WT HS143,
isogenic mutants HS143Dngt and HS143Dagt and its comple-
ments to A549 human adenocarcinoma lung epithelial cells
was investigated.
Actinobacillus pleuropneumoniae strain HS143, the wild-
type strain, was found to have a percentage of adherent cells
of 8.55+0.84, n ¼ 78 to A549 cells after 3 h incubation
(figure 2). In order to understand the role of the cytoplasmic
NGT in this adhesion phenotype, an in-frame deletion
mutant of the ngt gene was generated in A. pleuropneumoniae
and found to have a reduced percentage of adherent cells,
2.39+0.25 (n ¼ 78, p, 0.05), when compared with the wild-
type. This phenotype was restored (11.05+1.10, n ¼ 30, p.
0.05) upon complementation with the ngt gene. Furthermore,
when an a6GlcT deletion mutant in A. pleuropneumoniae was
tested for adherence, it was observed that there was a decrease
in adhesion (2.85+0.60, p, 0.05, n ¼ 30) to the same level
as the NGT mutant. However, complementation with the
ORF coding for a6GlcT was unable to rescue this phenotype
(figure 2). Gentamycin treatment of cells confirmed that
the bacterial counts observed were due to adhering and not
invading bacteria.3.2. Agt is part of a conserved putative operon that
includes ngt and rimO
Unlike NTHi, adjacent to the A. pleuropneumoniae N-linking
transferase gene, ngt, the flanking genes do not encode
an adhesin or a dedicated adhesin transporter (figure 1).
Instead, we identified an ORF coding for a protein
with amino acid similarity to 30S ribosomal protein S12
methylthiotransferase, rimO, upstream of ngt, and a secondglycosyltransferase-encoding gene downstream of ngt. Analy-
sis of all available A. pleuropneumoniae genomes demonstrated
that the genetic arrangement of the locus was absolutely
conserved in all published A. pleuropneumoniae genomes and
over 180 sequenced isolates (J.T.B. 2016, personal com-
munication). Reverse transcriptase-PCR (RT-PCR) was used
to analyse the expression of this locus in serovar 15 A. pleurop-
neumoniae reference strain HS143. Primers were designed
spanning intergenic regions between the three ORFs. Probe 1
tested if an mRNA transcript was generated between rimO
and ngt, and probe 2 tested for the presence of an mRNA tran-
script between ngt and agt. The results suggest that all three
genes form an operon (figure 3a). Further RT-PCR analysis
showed that the promoter driving rimO expression was
independent of the ORF immediately upstream (figure 3b).
Messenger RNA was extracted at different time points
during the growth of A. pleuropneumoniae and cDNAwas gen-
erated by RT-PCR using a probe designed within ngt. This
showed that ngt was transcribed at all-time points tested
(electronic supplementary material, figure S1).
3.3. Absolute quantification of rimO, ngt and agt by
qPCR
In order to further validate the hypothesis that rimO, ngt and
agt are co-transcribed, an absolute quantification qPCR was
performed. The results were normalized by the absolute
number of copies of rimO within each sample assuming rimO
is the first ORF in the operon and therefore the closest to the
putative promoter identified by bioinformatics analysis.
A trend was observed in all four biological replicates (n ¼ 12;
4 biologicals, 3 technical replicates) indicating a decrease
in expression level from rimO to agt consistent with the genetic
organization of the putative operon (rimO versus ngt, p, 0.05;
rimO versus agt, p, 0.001; figure 4).
3.4. Reconstruction of the NGT glycosylation operon and
its functional transfer and expression in Escherichia
coli
Following on from the RT-PCR studies indicating that both
agt and ngt were co-transcribed, we amplified by PCR the
two ORFs as a single amplicon and cloned them into the
IPTG-inducible expression vector pEXT20 [33], to generate
the plasmid pJC78. When the ORFs encoding a6GlcT and
NGT were co-expressed with a fragment of an autotrans-
porter adhesin from A. pleuropneumoniae (AtaC), which is a
natural acceptor [17], a reduction in protein migration on
SDS–PAGE was observed, indicating an increase in molecu-
lar weight consistent with the addition of an oligosaccharide
(figure 5).
To further understand the in vivo glycosylation operon,
individual mutations in ngt or agt were constructed within
the plasmid pJC78. NGT activity was abolished by substitut-
ing the conserved lysine residue at position 441 by alanine
(K441A) [18,20], whereas a6GlcT activity was abolished by
the replacement of the leucine codon at amino acid position
7 with a stop codon (L7*). Schwarz et al. [19] indicated that
in vitro, NGT and a6GlcT could assemble a glucose polymer
between two and six residues on an acceptor peptide. We
reasoned therefore that a commercially available antibody
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Figure 3. (a) Transcriptional analysis of the A. pleuropneumoniae NGT locus. Lane 1: cDNA as template; lane 2: RNA as template; lane 3: A. pleuropneumoniae HS143
genomic DNA positive control; lane 4: negative PCR control (no template). (b) Transcriptional analysis of the region upstream of ngt. Lane 1: cDNA as template; lane
2: genomic DNA positive control; lane 3: PCR control (RNA as template).
1.5 *
*
1.0
ex
pr
es
sio
n 
ra
tio
0.5
0
rim
O ng
t
ag
t
Figure 4. Absolute quantification of rimO, ngt and agt in A. pleuropneumoniae
strain HS143 expressed in fold change. Horizontal bars indicate pairs of columns
that are significantly different when compared with each other. Asterisk indicates
p, 0.05 (n ¼ 12).
kDa 1 2 3
100
70
kDa 1 2 3
100
70
(a)
(e) ( f )
(c) (d )(b)
Figure 5. Glycosylation analysis of AtaC1866 – 2428 alongside NGT and a6GlcT
by anti-dextran and anti-HIS western blots. Top panel: anti-dextran dot blot;
(a) dextran; (b) AtaC with NGT K441A and functional a6GlcT; (c) AtaC with
functional NGT and a6GlcT; (d ) AtaC with functional NGT only. Bottom panel:
anti-HIS and anti-dextran Western blots (e,f, respectively); lane 1, AtaC with
functional NGT and a6GlcT; lane 2, AtaC with NGT K441A and functional
a6GlcT; lane 3, AtaC with functional NGT only.
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7specific for a1–6 linked glucose tetrasaccharide (isomaltote-
traose) may be able to detect and verify the nature of the
polysaccharide generated by the cloned agt–ngt operon and
of the knockouts. Ni–NTA purified proteins from the three
construct combinations were tested for expression by dot
blot analysis using an anti-dextran monoclonal antibody
(mAb). This showed that a recognizable epitope could only
be generated when NGT and a6GlcT were both functional
(figure 5, top panel). SDS–PAGE and western blot analysis
using an anti-HIS monoclonal antibody showed a smear vis-
ible above the point at which AtaC should migrate, but only
when NGT and a6GlcT are both functional. This smearing
was also detected using the anti-dextran monoclonalantibody (figure 5f, lane 1). AtaC glycosylated appears to
migrate less than when detected by anti-HIS antibody,
because the anti-dextran antibody will only recognize AtaC
modified with four or more glucoses per site. Removing the
function of NGT yielded an AtaC fragment that migrated
to its unglycosylated location losing the epitope recognized
by the anti-dextran mAb (figure 5e, lane 2). Finally, knocking
out the function of a6GlcT reduced protein migration to a
slightly higher level than that observed with NGT mutation
alone (figure 5e, lane 3). This can be explained by glyco-
sylation with a single hexose at multiple sites within the
acceptor protein. Furthermore, this material was not recog-
nized by anti-dextran mAb, suggesting that glycosylation
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Figure 6 (a) NP-HPLC analysis of 2-AB labelled glycans released from purified AtaC which was co-expressed with NGT and a6GlcT in E. coli DH10b (black).
A glucose homopolymer (dextran) ladder serves as a reference for retention time (red). The peak originating from excess 2-AB label (rt ¼ 4.1 min) is marked
with an asterisk. (b,c) MALDI mass spectrometry analysis of the same glycan sample confirms the identity of the observed glycan chains as a hexose polymer.
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8had occurred, but that no polymer had been generated
(figure 5f, lane 3).3.5. Confirmation of hexose build-up on AtaC
In order to confirm the identity of the observed post-transla-
tional modification of AtaC, the glycans from purified protein
were released by hydrazinolysis, fluorescently labelled with
2-aminobenzamide (2-AB) and analysed by normal-phase
HPLC (figure 6a).
With a labelled dextran ladder used as a reference, this
analysis revealed the presence of glycan chains of varying
lengths (1–27 monosaccharide units). This was further con-
firmed by MALDI-MS analysis. Peaks differing in mass by
162 Da suggested potential for glucose or galactose attach-
ment (figure 6b,c). Therefore, the results from both methods
were in agreement showing a hexose polymer ranging up
to at least 20 units.
To confirm that particular sites on the protein were modi-
fied with these elongated glycans, LC–ESI–MS/MS analysis
of glycosylated AtaC was performed (figure 7 and table 1).
This showed that previously identified glycosylation sites
were occupied [17]. In total, 15 asparagine (Asn) residues
were identified as being modified with glycan chains of vari-
able length. For example, glycopeptide GNLSTAADVTDK
could be detected modified with an N-linked glycan consist-
ing of 1–29 hexose units (table 1). On other sites, only short
glycan chains could be detected, whereas one peptide
(NISTVVK) could only be detected as being modified withglycan chains of more than 14 hexoses. These results are sum-
marized in table 1 and confirm western blot evidence that
co-expression of NGT and a6GlcT leads to the formation of
Asn-linked, linear hexose chains of up to 29 units in length.3.6. The ngt/agt operon can be used to modify
alternative substrates with dextran
Following assembly of plasmid pJC78, we began testing if the
ngt/agt operon could be used to make N-linked glucose poly-
mers on non-native substrate proteins in a similar manner to
NGT alone [17]. We selected Cj0114 from the 1-proteobacter-
ium Campylobacter jejuni as a scaffold for designing a new
acceptor protein. The native Cj0114 tetratricopeptide domain
was removed to reduce protein toxicity and simplify purifi-
cation. At the C-terminus of the protein, the 12 added NAT
glycosylation sequons were followed by a hexa-histidine tag
to enable protein purification. The new protein, named JC1,
was constitutively expressed from the plasmid pJC1. Combin-
ing the plasmids pJC1 and pJC78 generated an epitope that
could be recognized by the anti-dextran mouse mAb; this dis-
appeared upon knocking out the function of ngt or agt
(figure 8). The marginally different sizes in the anti-His and
anti-dextran western blot are due to the recognition epitope
for the anti-dextran antibody, where only highly polymerized
proteins are detected (acceptors modified with four or more
glucose residues). These findings indicated that NGT and
a6GlcT can be made to target any protein.
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94. Discussion
Novel bacterial glycosylation systems are regularly being dis-
covered as glycan analyses methodologies improve [34–37].
The functions of these glycosylation systems are yet to be
fully appreciated, but it is now apparent that glycosylation
is a feature common to most bacteria.In this study, we report the investigation of a cytoplasmic
glycosylation system in a member of the Pasteurellaceae family,
A. pleuropneumoniae. Our results demonstrate that despite simi-
larities between NGT and its orthologue, HMW1C, in NTHi,
the system described here is unique. The A. pleuropneumoniae
N-linking locus consists of two co-transcribed glycosyl-
transferases (ngt and agt) with no associated adhesin or
Table 1. Summary of glycosylation status for each site from AtaC. Underlined letters: in red, N-X-S/T sequons; in blue, asparagine residues found to be
occupied but not part of an N-X-S/T consensus sequon.
tryptic peptide peptide sequence glycan
1 ELNETLTIK Hex1–5
2 GNLSTAADVTDK Hex1–29
3 VINVAAGDVNANSTDAVNGSQLYAVSEVANK Hex1–14
4 GWNIQTNGNDTTNVKPGDTVNFVNGDNIAITNDGTK Hex1–15
5 VGDNVSLTK Hex3–19
6 GANVTQNLGK Hex1–20
7 NISTVVK Hex14–20
8 DGSLTIGNTTINSDQVK Hex1–22
9 VSGVADGDISPNSTEAINGSQLYDANQNIANYLGGGSK Hex1–13
10 VDGNTTTANNVGDAITNLNNEVVKPLTFEGDTGVASK Hex1–12
11 TVNANTVNANTVK Hex1–6
12 AGQADTDAVNVSQLK Hex1–5
kDa
(a)
(b)
55
35
kDa
55
35
Figure 8. Glycosylation of engineered acceptor protein (JC1) by NGT and
a6GlcT. (a) Amino acid sequence of the new target glycoprotein JC1. High-
lighted in yellow are glycosylation sequons, and in red, the hexa-HIS tag used
for protein purification. (b) Glycosylation of the acceptor protein JC1 with
NGT and a6GlcT. Left panel: anti-histidine tag western blot; right panel,
anti-dextran western blot. Lane 1: JC1 expressed with functional NGT and
a6GlcT; lane 2: JC1 with NGT K441A and a6GlcT; lane 3: JC1 with NGT
but non-functional a6GlcT.
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10transporter. Another significant difference between the
A. pleuropneumoniae system and that of NTHi is that the promo-
ter for rimO, upstream of ngt, appears to be responsible for
driving transcription of ngt and agt (figure 3). Recent studies
have shown that in Aggregibacter aphrophilus and Haemophilus
ducreyi [16,21] hmwC is also located downstream of rimO,
although a transcriptional link has yet to be proven [21]. In
E. coli, RimO is an enzyme that catalyses the methylthiolation
of ribosomal subunit S12 at the universally conserved D88
residue. Furthermore, it has been shown that knocking
out rimO in E. coli leads to a growth defect [38,39]. The signifi-
cance of RimO has also been reported in Thermus thermophilus,
where residue D88 cannot be mutated [40], leading to the
conclusion that although methylthiolation is not essential in
every organism, RimO clearly plays an important role in main-
taining bacterial fitness [39]. Our tests indicate that the
A. pleuropneumoniae rimO promoter is active at every time
point tested, suggesting that ngt and agt are constitutivelyexpressed (electronic supplementary material, figure S1), and
therefore the cytoplasmic N-linking glycosylation system is
always available to modify substrate proteins. Furthermore,
qPCR analysis of the locus indicated transcriptional levels
consistent with an operonic structure, where the highest level
of transcription detected was of rimO, followed by ngt
and agt, respectively (figure 4). This is in agreement with the
findings reported by Lim et al. [41] whereby the expression
level of the genes proximal to the promoter was greater than
the ones farthest from it. Bioinformatic analysis of the DNA
sequence surrounding the putative rimO/ngt/agt operon ident-
ifies a transcriptional promoter just upstream of rimO and a
Rho-independent terminator downstream of agt (electronic sup-
plementarymaterial, figure S2) [42].Nevertheless, to gain further
insights into the regulation of the locus, other approaches such as
RNAseq couldbe carriedout. Furthermore, in silico analysis of all
publically available genomes and over 180 others (J.T.B. 2016,
personal communication) indicates that the gene order is
absolutely conserved (data not shown).
In thiswork,we also demonstrate thatNGTplays an impor-
tant biological role in the ability ofA. pleuropneumoniae to adhere
to A549 human adenocarcinoma lung epithelial cells, which,
although from human origin, are from biologically relevant
tissue. The rationale for using A549 cells, instead of St Jude
Porcine lung (SJPL) cells, which have been widely used to
assess A. pleuropneumoniae adhesion [4,43,44], was that the
SJPL cell line was found to be misclassified, and is simian in
origin [45]. In order to draw absolute conclusions regarding
the role of this N-linked glycosylation system in aidingA. pleur-
opneumoniae pathogenesis in the pig, the adhesion assay data
that obtained in this study could be extended to investigate
other tissues such as ex vivoorgan cultures [46] possibly primary
cell cultures from pig lung epithelial cells.
Similarly to our study, a significant reduction in adherence
was reported for E. coli expressing the cloned hmw1 locus from
NTHi when the function of HMW1C (the NGT orthologue)
was removed [15]. The hmw1/hmw2 loci and the ngt operon
differ in that the NTHi loci encode an adhesin and an adhesin
transporter alongside hmwC, whereas the A. pleuropneumoniae
locus encodes an a6GlcT polymerizing glucosyltransferase
(figure 1). Surprisingly, knocking out the function of the
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11a6GlcT transferase also resulted in a significant reduction in
adherence comparable to that detected when NGT activity
was abolished. Plasmid-based complementation with agt
only (figure 2) and ngt/agt (data not shown) proved insufficient
to rescue the adhesion phenotype seen with the wild-type.
Our failed attempts to rescue the phenotype suggest a need
for fine transcriptional control of agt levels in the bacterium.
It is possible that, when ngt is being expressed in the chromo-
some and agt is on a plasmid, over-glycosylation of target sites
occurs, resulting in incorrect adhesin structural conforma-
tion. Potentially, this incorrect folding could prevent surface
presentation or adhesin function.
Some of the best-studied examples of glycosylated autotran-
sporter adhesins are O-linked, and found in E. coli. O-linked
glycosyltransferases can glycosylate TibA, Ag43 and AIDA-I
in their passenger domains [47–49]. Bioinformatic analysis
of the autotransporter adhesin used in our study, AtaC from
A. pleuropneumoniae AP76 (GenBank accession number
ACE61172.1), indicated the presence of 72 NX-(S/T) sequons.
The majority of these (59/72) are localized in the passenger
domain of the adhesin, further demonstrating the similarities
with the O-linked counterparts. Whether glycosylation is
required, so that the adhesin assumes the correct conformation
and is not degraded as observed in AIDA-I, or if it is so that the
adhesin can adopt a conformation suited for adhesion as
described in TibA [50], remains to be determined even in
these well-studied proteins.
Our demonstration of glucose polymer assembly within
E. coli cells, when the ngt/agt locus is overexpressed alongside
an acceptor protein (figure 5), led us to investigate if this glycan
couldbedetectedon the surfaceofA.pleuropneumoniae. Immuno-
fluorescence studies using an anti-dextran antibody that
recognizes isomaltotetraose as a minimum epitope failed to
detect any signal, even in permeabilized cells (data not shown).
This suggests that although the capabilityexists to forma-1,6 glu-
cose chains greater than four subunits heterologously, in
A. pleuropneumoniae the necessary epitope for detection with
anti-dextran antibody does not appear to be formed. Analysis
of the glycosylated peptides generated within E. coli, as deter-
mined by peak quantification of the HPLC chromatogram
(figure 6), revealed a steady decrease in abundance of the oligo-
saccharide with increasing chain length. It was however
noteworthy that the peak corresponding toGlc2-2AB (retention
time: 8.8 min) was considerably smaller than the peaks corre-
sponding to Glc1-2AB and Glc3-2AB, indicating that the
addition of the first a1–6-linked glucosemight be considerably
slower than the subsequent transfer reactions. This suggests
that the first a6GlcT-catalysed reaction is, in fact, the rate-limit-
ing step in the biosynthesis of these extended N-glycan chains.
In a review of the HMWC literature, we found instances
where adhesin glycopeptides with dihexose modifications
have been reported, in the absence of a co-localized ORF-like
agt [15,51]. Rempe et al. [21] report dihexose modifications on
four glycopeptides belonging to the autotransporter adhesin
of K. kingae. These raise several possibilities; the first is that the
reported glycopeptides actually contain two individual hexose
attachments and not two hexoses together. Second, it may be
possible that the HmwC from K. kingae is able to catalyse
N-linked attachment and subsequent polymerization. Third,
one cannot rule out there may be another glycosyltransferase
in the genome that is enabling dihexose assembly.
A review of the NGT-specific literature reveals an interest-
ing disparity in the function of this enzymewhen tested in vitroand in vivo.Choi et al. [51] reported that in vitro,NGT is capable
of forming dihexoses. However, this study indicates that
a6GlcT is essential for glycosidic bond formation and exten-
sion of the glucose polymer in vivo. This is in agreement
with a previous study by Naegeli et al., which failed to
detect any polymerization when NGT alone was expressed
in E. coli to glycosylate an acceptor protein [17].
Our finding that a6GlcT function is necessary to maintain
adhesion in A. pleuropneumoniae indicates that this enzyme
must be extending glucose residues at some sites within
the autotransporter adhesins. However, by transferring the
N-linking glycosylation locus into E. coli, we showed that
a6GlcT and NGT are unable to fully complement each other’s
functions. Our study also provides further evidence that
‘orphan’ HMWC family of enzymes that have not evolved to
be co-localized with their target substrate continue to modify
proteins involved in adhesion. It is noteworthy that every bac-
terial species reported thus far with this genetic arrangement
uses the glycosylation system to target autotransporter adhesins
[16,21]. Glycosylation has been linked to protection fromproteo-
lytic degradation, correct protein folding and correct transport to
the surface, all of which would have an effect on cell adhesion.
Further studies are ongoing to ascertain the level of interaction
between a6GlcT/NGT and the target protein(s).
By demonstrating how to harness the ngt/agt operon, we
have shown potential for glycoengineering applications,
including the generation of N-linked glucose-based conjugate
vaccines against A. pleuropneumoniae. The genetic conserva-
tion of the ngt operon in A. pleuropneumoniae would favour
the development of a glycoconjugate vaccine against multiple
A. pleuropneumoniae serovars. Other potential applications
include the development of dextran-based conjugates that
may be useful against bacteria such as Helicobacter pylori
[52]. Recently, such conjugates have been shown to be immu-
nogenic, and post-immune sera from rabbits vaccinated with
dextran-based conjugates exhibited activity against strains of
H. pylori that contain a(1–6) glucose as part of their LPS [52].
The field of bacterial glycobiology is burgeoning and
investigations into various glycosylation systems, such as
the NGT/a6GlcT system reported here, help to understand
their functional roles. Our results demonstrate the impor-
tance of genetic and phenotypic screens for investigating
glycosylation systems, and that this data can directly benefit
bacterial glycoengineering.
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